Table 1.
US Study Group | International Study Group |
||
---|---|---|---|
Patients | N (%) | N (%) | p1-value |
Total | 167 (100%) | 237 (100%) | |
Range age (years) | 17–87 | 17–87 | 0.072 |
Mean age (SD) | 36.8 (15.3) | 34.6 (15.1) | |
Median age (IQR) | 32 (25;46) | 30 (23;40) | |
18–32 years | 86 (51.5%) | 138 (58.2%) | 0.233 |
33–47 years | 43 (25.8%) | 50 (21.1%) | |
48–62 years | 21 (12.6%) | 28 (11.8%) | |
>62 years | 17 (10.2%) | 19 (8.0%) | |
NA | - | 2 (0.8%) | |
p2-value | |||
Menstruation | 19 (11.4%) | 25 (10.6%) | 0.943 |
PMS | 8 (4.8%) | 20 (8.4% | 0.201 |
Menopause | 11 (6.6%) | 19 (8.0%) | 0.676 |
Pregnancy | 0 (0%) | 27 (11.4%) | <0.001 |
Diabetes mellitus | 2 (1.2%) | 2 (0.8%) | 1.000 |
SD, standard deviation; IQR, interquartile range; PMS, premenstrual syndrome. p1, Wilcoxon–Mann–Whitney test; p2, chi-square test.